The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease ProgressionKhalil Choucair, Jacques Lapointe, Karl‐Philippe Guérard et al.|Translational Oncology|2012Cited by 39
Glutamyl Adenylate Analogues Are Inhibitors of Glutamyl-tRNA SynthetaseMichel Desjardins, Robert Chênevert, Sylvie Garneau‐Tsodikova et al.|Bioorganic Chemistry|1998Cited by 18
Synthesis of inhibitors of glutamyl-tRNA synthetaseMichel Desjardins, Robert Chênevert, Fu De Yang et al.|Bioorganic & Medicinal Chemistry Letters|1997Cited by 8
Abstract C25: The 16p13.3 genomic gain in prostate cancer: A role for PDK1 in disease progressionKhalil Choucair, Jeremy A. Squire, Fadi Brimo et al.|Cancer Research|2012Cited by 0